ACE2 ACTIVATION FOR THE TREATMENT OF CARDIAC, PULMONARY AND RENAL DISEASES AND HYPERTENSION.

摘要

A use of a therapeutically effective amount of an ACE2 polypeptide or ACE2 nucleic acid for the preparation of a medicament for the treatment of a decreased ACE2 state selected from hypertension, congestive heart failure, chronic heart failure, acute heart failure, heart attack myocardium, arteriosclerosis, renal failure or a lung disease in a mammal, in which the lung disease is chronic obstructive pulmonary disease, pneumonia, asthma, chronic bronchitis, pulmonary emphysema, cystic fibrosis, interstitial lung disease, primary pulmonary hypertension, pulmonary embolism, pulmonary sarcoidosis, tuberculosis, pulmonary edema, ARDS or lung cancer.